Paul Hastings, Sidley Austin, and Maples Group have advised Accelerant. Houlihan Lokey and Conyers Dill & Pearman have advised the Special Committee of Accelerant. Goodwin Procter,...
Accelerant Enters Into $4 Billion Take-Private Acquisition by Thoma Bravo
AvalonBay Communities and Equity Residential Announce All-Stock Merger of Equals
Wachtell, Lipton, Rosen & Katz has advised Equity Residential. Goodwin has advised AvalonBay Communities Inc. Skadden has advised Goldman Sachs as financial advisor to AvalonBay Communities....
Centerbridge Partners to Acquire MeridianLink in $2 Billion All-Cash Transaction
Kirkland & Ellis has advised Centerbridge Partners, and Goodwin Procter has advised MeridianLink. Skadden has advised Thoma Bravo, MeridianLink, Inc.’s largest shareholder. Paul Hastings LLP represented...
AVROBIO’s Merger with Tectonic Therapeutic
Leerink Partners is serving as exclusive financial advisor to Tectonic and Cooley LLP is serving as legal counsel to Tectonic. Leerink Partners and TD Cowen are...
SunMed’s $110 Million Acquisition of Avanos’ Respiratory Health Business
Goodwin Procter is serving as legal counsel to SunMed, and Alston & Bird is serving as legal counsel to Avanos. SunMed announced it has entered into...
Quest Diagnostics’ Acquisition of Haystack Oncology
Goodwin advised Haystack Oncology on the deal. Haystack Oncology announced its definitive agreement to be acquired by Quest Diagnostics (NYSE: DGX). Under the terms of the agreement,...
TCR² Therapeutics’ Agreement with Adaptimmune Therapeutics
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
Sun Pharmaceutical’s $576 Million Acquisition of Concert Pharmaceuticals
Davis Polk advised Sun Pharmaceutical, and Goodwin Procter advised Concert Pharmaceuticals. Sun Pharmaceutical Industries Limited announced its acquisition of Concert Pharmaceuticals Inc., through a tender offer for an...
Takeda’s Acquisition of NDI-034858 from Nimbus Therapeutics
Cleary Gottlieb represented Takeda in the transaction while Goodwin Procter advised Nimbus Therapeutics. Takeda (TSE:4502/NYSE:TAK) announced that it will acquire NDI-034858 from Nimbus Therapeutics. NDI-034858 is...
Ritchie Bros’ $7.3 Billion Acquisition of IAA, Inc.
Goodwin Procter, McCarthy Tétrault and Skadden, Arps, Slate, Meagher & Flom advised Ritchie Bros. Incorporated, while Cooley and Blake, Cassels & Graydon advised IAA on the...
Amazon.com’s $1.7 Billion Acquisition of iRobot Corporation
Goodwin Procter advised iRobot Corporation on the deal, while Paul, Weiss advised Amazon. iRobot Corporation (NASDAQ: IRBT) announced its definitive agreement to be acquired by Amazon.com, Inc....
TA Associates’ Investment in Veracode
Goodwin Procter advised TA Associates on the deal. TA Associates announced its strategic growth investment in Veracode, taking a majority equity position in the business. Veracode is...